Oncology Vol 32 No 7
Natalia Pin Chuen Zing, MD, MSc;Thais Fischer, MD;Jasmine Zain, MD;Massimo Federico, MD;Steven T. Rosen, MD
July 15th 2018Article
This two-part series highlights the most important aspects of PTCLs and describes current treatment options and investigative opportunities. Part 1 will cover PTCL not otherwise specified, follicular T-cell lymphoma, angioimmunoblastic T-cell lymphoma, anaplastic large-cell lymphoma (ALCL), and breast implant–associated ALCL.
